TRI-LO-SPRINTEC

NORGESTIMATE AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TRI-LO-SPRINTEC, covering 2009-06-29 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: TRI-LO-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)